Stivarga 40 mg, 84 tablets (Regorafenib 40 mg per tablet) by Bayer.
Indications: Metastatic colorectal cancer, GIST and hepatocellular carcinoma after prior therapy.
Administration: Oral: 160 mg (4 tablets) once daily for 3 weeks, then 1 week off, after a light low-fat meal.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Bayer |
| Active ingredient | Regorafenib 40 mg per tablet — multikinase inhibitor. |
| Strength & pack | 84 film-coated tablets (3 bottles × 28). |
| Form | Film-coated tablets |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |